Treatment with VX-661 and Ivacaftor in a Phase 2 Study Resulted in Statistically Significant Improvements in Lung Function in People with Cystic Fibrosis Who Have Two Copies of the F508del Mutation
Otrzymuj każdy nowy wpis na swoją skrzynkę e-mail.
Adres e-mail:
Śledź